United Kingdom· GB-APID-12279611000001104
Nicotinamide 25mg/5ml oral solution
A nicotinamide product containing nicotinamide, registered in United Kingdom by Special Order. The same ATC class is registered in 8 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Nicotinamide is registered in 8 of 19 countries.
Countries holding a registration under ATC A11HA01 (nicotinamide), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 5 of them publish a price we can compare per daily dose
Nicotinamide · ATC A11HA01
8 / 19 countries
- Belgiumprice
- Franceprice
- Germany
- Japan
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Nicotinamide
- Manufacturer
- Special Order
- Country
- United Kingdom (GB)
- ATC code
- A11HA01
- ATC class
- Nicotinamide
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
83 interactions on record for nicotinamide.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nicotinamide · interactions on record
83 records
- 7 severe
- 75 moderate
- 1 minor
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- PexidartinibL01EX15severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Nicotinamide in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United States4 IN LOOK Ginseng Anit wrink Anti wrinkle essenceGuangzhou Yanhou Cosmetics Co., Ltd.
- NorwayNAD+ Cell RegeneratorLife Extension
- FranceNICOBION 500 mg, comprimé pelliculéTEOFARMA
- BelgiumBecozymeBayer
- PolandVitaminum PP 200 mgPolfarmex S.A.
- Japanニコチン酸アミドＮＩＳＳＨＡゾンネボード製薬
- IrelandNicam 4% w/w GelDermal Laboratories (Ireland) Limited
- GermanyNicotinamid AxicurAxicorp Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Belgium · Nicotinamide Sterop
- Germany · Nicotinamid Axicur
- France · Nicobion, Nicotinamide Renaudin
- Ireland · Nicam
- Italy · Nicotinamide Idi
- Poland · Vitaminum Pp Polfarmex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fd283a67-dc90-4edd-b1c4-5337b2f246fb GET /v1/drugs/fd283a67-dc90-4edd-b1c4-5337b2f246fb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "12279611000001104",
"desc": "Nicotinamide 25mg/5ml oral solution (Special Order)",
"form": "Oral solution",
"vpid": "12302811000001108",
"source": "dmd",
"vtm_id": "13297701000001102",
"strength": "5 mg",
"substance": "Nicotinamide",
"ingredient": "Nicotinamide",
"supplier_code": "8286711000001104"
}See everything about nicotinamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.